Investors
Advitech is a health sciences and technology company with a mission to discover and commercialize proprietary and evidence-based natural health products. Effective and safe, these products play a role in the prevention of immune-mediated inflammatory disorders, such as psoriasis and inflammatory bowel disease. Advitech produces Dermylex® for the treatment of mild-to-moderate psoriasis.
Advitech has drawn up a research program to develop new applications related to wound healing. This development is derived from both its XP-828L and IM technological platforms.
-
- Sedar
-
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR OF ADVITECH INC.
For the Annual General Meeting of Shareholders to be held on June 1, 2011
Download this notice (PDF 24 KB) - FAQ
- Download our corporate profile (PDF 480 KB)
- Finances
-
-
Contacts:
Michael Stangel: Send an e-mail
President/CEO
(215) 604-0631